Mark A. Schlossberg
2014
In 2014, Mark A. Schlossberg earned a total compensation of $2.1M as Senior Vice President, General Counsel and Corporate Secretary at Impax Laboratories, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $438,258 |
|---|---|
| Option Awards | $584,100 |
| Salary | $484,225 |
| Stock Awards | $580,520 |
| Other | $52,758 |
| Total | $2,139,861 |
Schlossberg received $584.1K in option awards, accounting for 27% of the total pay in 2014.
Schlossberg also received $438.3K in non-equity incentive plan, $484.2K in salary, $580.5K in stock awards and $52.8K in other compensation.
Rankings
In 2014, Mark A. Schlossberg's compensation ranked 4,244th out of 13,032 executives tracked by ExecPay. In other words, Schlossberg earned more than 67.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,244 out of 13,032 | 67th |
Division Manufacturing | 1,501 out of 4,966 | 70th |
Major group Chemicals And Allied Products | 493 out of 1,686 | 71st |
Industry group Drugs | 381 out of 1,365 | 72nd |
Industry Pharmaceutical Preparations | 304 out of 1,043 | 71st |
Source: SEC filing on April 14, 2015.
Schlossberg's colleagues
We found six more compensation records of executives who worked with Mark A. Schlossberg at Impax Laboratories in 2014.
2014
G Wilkinson
Impax Laboratories
Chief Executive Officer
2014
Larry Hsu
Impax Laboratories
Chief Executive Officer
2014
Carole Ben-Maimon
Impax Laboratories
Former President, Impax Generics Division
2014
Michael Nestor
Impax Laboratories
President, Impax Specialty Pharma division
2014
Bryan Reasons
Impax Laboratories
Chief Financial Officer
2014
Jeffrey Nornhold
Impax Laboratories